Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000542011 | SCV000653500 | likely benign | Cowden syndrome 6 | 2023-10-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000136 | SCV001156586 | likely benign | not specified | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341444 | SCV002641321 | likely benign | Inborn genetic diseases | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV000542011 | SCV004017021 | likely benign | Cowden syndrome 6 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003935508 | SCV004752221 | likely benign | AKT1-related disorder | 2019-02-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |